|
Real World retrospective study of effectiveness and safety of Gilenya (FINgOlimod) in relapsing remitting Multiple Sclerosis in the Middle East and North Africa (FINOMENA)
|
Ongoing
|
Fingolimod
|
4
|
TY720DAE01
|
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Hospital (Jeddah), King Abdulaziz Hospital Oncology Center, King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), Al-Noor Specialist Hospital (Makkah), Hira Hospital (Makkah), King Fahad Specialist Hospital (Dammam), Dr. Erfan & Bagedo General Hospital (Jeddah)
|
|
A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis
|
Ongoing
|
ofatumumab
|
3
|
COMB157G2301
|
King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Randomized, Open-label Trial of Paritaprevir Plus Ritonavir Plus Ombitasvir in the Treatment of HCV Genotype 4 Infected Patients with Stage 4-5 Chronic Kidney Disease
|
Ongoing
|
ombitasvir \ paritaprevir \ ritonavir
|
3
|
Version 1.3.1
|
King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Hospital (Jeddah)
|
|
"Open-label, multicenter, single arm, phase II study assessing treatment patient preference for new deferasirox formulation (film-coated tablet) compared to the reference deferasirox dispersible tablet formulation"
|
Ongoing
|
deferasirox
|
2
|
CICL670FIC05
|
King Abdulaziz University Hospital (Jeddah), Hereditary Blood Disease Center (al ahsa), King Abdulaziz Medical City NG (Riyadh)
|
|
International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan
|
Terminated
|
Lixisenatide
|
3
|
LPS14410
|
King Khalid University Hospital (Riyadh)
|
|
A Phase II Study to examine the efficacy and safety of a new drug called Sevuparin on resolution of painful vaso-occlusive crisis in patients with sickle-cell disease.
|
Ongoing
|
Sevuparin
|
2
|
TVOC01
|
King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Qatif Central Hospital
|
|
Multicenter Inetrnational neoadjuvant randomized double-blind trial comparing fulvestrant to a combination of fulvestrant and palcociclib in patients with operable luminal breast cancer responding to fulvestrant
|
Ongoing
|
palbociclib fulvestrant
|
3
|
ICRG 1201
|
King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah)
|
|
A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age
|
Ongoing
|
Elaprase
|
4
|
SHPELA401
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A MULTICENTER, PROSPECTIVE, OBSERVATIONAL, NON-INTERVENTIONAL STUDY EVALUATING THE EFFICACY AND SAFETY OF USING TOCILIZUMAB (TCZ) FOR CONFIRMED RHEUMATOID ARTHRITIS (RA) PATIENTS IN CLINICAL PRACTICE
|
Ongoing
|
tocilizumab
|
4
|
ML299336
|
King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh)
|
|
"CLCZ696B2401-TRANSITION (A multicenter, randomized, open label, parallel group studycomparing pre-discharge and posT-discharge tReatmentinitiation with LCZ696 in heArt failure patieNtS withreduced ejectIon-fracTion hospItalized for an acutedecOmpensation eveNt (ADHF)"
|
Ongoing
|
Entresto (SACUBITRIL, VALSARTAN)
|
4
|
CZ696B2401
|
Saud Al-Babtain Cardiac Center (Dammam), King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Khalid University Hospital (Riyadh)
|
